If you heard about a disease that almost exclusively targets one race, you'd think it was some kind of conspiracy. But nope, ...

A 58-year-old male patient presented to the dermatology clinic at West China Hospital of Sichuan University (Chengdu, Sichuan ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Discover how the medicinal orchid Dendrobium officinale (Tiepi Shihu) improves salivary gland function, reduces inflammation, ...

“What I valued most about the (NY) Quitline was their empathy,” Melvin said. “Their follow-up calls gave me the support I ...

Hyperion Functional Medicine introduces a transformative approach to cancer care through its Functional Oncology program, designed to optimize treatment, ...

在此背景下，具有类过氧化氢酶活性的纳米酶因其独特的优势而备受关注。它们能够在肿瘤微环境中催化过氧化氢分解，原位持续生成氧气，从而改善肿瘤乏氧状态。相比传统方法，纳米酶有效避免了氧气消耗迅速、难以控制或毒性显著等问题，更符合临床实际需求。然而，要实现纳米酶的高效应用，关键在于精准靶向乏氧病灶。然而，目前对乏氧肿瘤细胞表面标志物的了解尚有限，这在一定程度上阻碍了靶向策略的开发。

The Hyderabad-based drug major had reported a profit of Rs 1,379 crore for the October-December period of last fiscal. Revenue increased to Rs 8,359 crore from Rs 7,215 crore a year ago.

China-based Kelun-Biotech Biopharmaceutical has received marketing authorization in China from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed ...

LEO Pharma will be gaining the rights to commercialise Junshi Biosciences’ toripalimab in Europe under a new distribution and ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...